安进将其在美国直接向消费者销售的胆固醇药物Repatha价格降低近60%。公司指出,新项目面向符合条件的美国患者开放,包括没有保险或倾向以现金支付药物费用的患者。
安进将其在美国直接向消费者销售的胆固醇药物Repatha价格降低近60%。公司指出,新项目面向符合条件的美国患者开放,包括没有保险或倾向以现金支付药物费用的患者。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.